The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Nov. 14, 2014
Applicant:

Otago Innovation Limited, Dunedin, NZ;

Inventors:

Jacqueline Amanda Lee, Christchurch, NZ;

Christopher Joseph Pemberton, Christchurch, NZ;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); C07K 16/18 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C07K 14/4716 (2013.01); C07K 16/18 (2013.01); G01N 33/6887 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); G01N 2333/4712 (2013.01); G01N 2800/32 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention relates generally to assays, methods and kits for the prognosis and/or diagnosis of cardiac disorders. The present invention also provides, for example, binding agents to a novel class of circulating cardiac troponin T upstream open reading frame (TnTuORF) peptide biomarkers for use in predicting or diagnosing a cardiac disorder other than myocardial infarction or unstable angina. In addition, the binding agents of the present invention may be used to enhance the sensitivity and false positive performance of cardiac troponins in the prognosis and diagnosis of myocardial infarction.


Find Patent Forward Citations

Loading…